Abstract:
I. Introduction
Photodynamic therapy Photodynamic therapy (PDT) depends on the use of photochemical reactions mediated through the interaction of photosensitizing substances (photosensitizers), light, and oxygen for the treatment of malignant or benign diseases [1] . In the first step, the photosensitizer is administered to the patient by one of several routes (eg, topical, oral, intravenous), and it is allowed to be taken up by the target cells. The second step involves the activation of the photosensitizer in the presence of oxygen with a specific wavelength of light directed toward the target tissue [2] . Because the photosensitizer is preferentially absorbed by hyperproliferative tissue and the light source is directly targeted on the lesional tissue, PDT achieves dual selectivity, minimizing damage to adjacent healthy structures. Upon absorption of photons of light, the photosensitizer is excited to a short-lived singlet state followed by a transition to the reactive triplet state. From its triplet state in the presence of oxygen, reactive free radicals and singlet oxygen species ensue. These, in turn, react with cell membranes, causing direct damage to the mitochondria, endoplasmic reticulum, and/or plasma membranes [3] .
II.

Tissues
There exists considerable current interest in the use of optical methods for medical imaging, diagnosis and therapy [4] . Encouraging results have already been obtained for use of optical techniques for in situ monitoring of tissue parameters, discrimination of diseased tissue from normal, mammography, and several therapeutic applications. For most of these applications, in particular for the use of light in therapy, it is important to be able to predict the spatial distribution of light in the target tissue [5] .
III. Fluorescence
Emission of fluorescence is one of the possible processes that can occur when light is absorbed in molecules. Following the absorption of a photon and the subsequent excitation of the absorbing molecule, the molecule relaxes down to the lowest energy level within the S 1 s t a t e , by a non-radiative process (Figure 1 ). From here, it can release its extra energy by emitting a photon as it relaxes down to the lower S 0 e n e r g y state. This emission is called fluorescence. Due to the energy loss in the non-radiative part of this process, the fluorescence photon will carry a lower energy and, thereby, have a longer wavelength than that of the absorbed photon. The relaxation from the higher level can end in any level in the lower S 0 energy band, leading to a total fluorescence emission composed of several wavelengths. This explains why fluorescence is characterized by a wide wavelength distribution and not by a sharp peak [6] . The shorter the excitation wavelength, i.e. the more towards the ultraviolet region the fluorescence excitation occurs, the more of the visible spectrum can be contained in the resulting fluorescence signal [7] Fig (1) showed fluorescence excitation diagram
Fluorescence imaging
Fluorescence imaging is potentially a very powerful tool. However, the traditional process of labeling cells and biological tissue is invasive, tending to damage them or alter their normal function and so fluorescence techniques have so far been limited in their application [8] . This technique offers the prospect of a non-invasive clinical imaging method if one can use fluorescence to contrast different types or states of tissue, e.g. healthy, diseased and tissue activities before and after treatment especially during photodynamic therapy in which we need to monitor the tissue uptake of the applied photosensitizer, provides a further dimension that help in enhancement of PDT process [9] Image Profile:
A line profile plots the variations of intensity along a line. It returns the grayscale values of the pixels along a line and graphs it. Line profiles are helpful for examining boundaries between components, quantifying the magnitude of intensity variations, and detecting the presence of repetitive patterns [10] IV.
Materials and Methods
Experimental Setup:
There are various types of methods and instruments used for in vivo fluorescence imaging essentially have the same basic components, except for a few differences [11] . The experimental setup basically consists of either a broadband or monochromatic excitation light source, a dispersing element or filter to spectrally select the excitation band, a delivery and collection conduit for the delivery of excitation light to, and the collection of the emitted light from the imaging surface of the biological medium, a dispersing element or filter to spectrally select the emitted light, and a multi-or single-channel detector, which measures the spatial and/or spectral distribution of the intensity of the emitted light. The detection system consists of Charge Coupled Device CCD camera, the filters were chosen based on the spectral characteristics of tissue and the used photosensitizer [12] -amino levulinic acid (-ALA), which activated at 635 nm and excited at 375-440 nm. (-ALA) Fluorescence analyses were performed by exciting the sample with 405-nm light and monitoring the resulting fluorescence with a computer display over the spectrum of 635 nm. The image is transmitted through a spatially coherent optical fiber bundle and is spectrally filtered with a 400-nm long-pass filter prior to detection [13] . A schematic of the basic components of such an instrument is shown in Figure ( In vivo cellular uptake showed that there was significantly increased uptake of -amino levulinic acid (-ALA) after p h o t o d y n a m i c t h e r a p y irradiation. In vivo bio-distribution of aminolevulonic acid ALA in tumor-bearing rats' thigh tissues showed increased the uptake of ALA Conversely, red fluorescence intensities showed a time-dependent decrease with the same time period of applying photodynamic therapy, almost as that obtained from normal tissues. Matlab analysis and image processing of obtained images confirmed that the tumors uptake for ALA increased by time and exposure to light. There was a significant difference of RGB pixels intensities between normal, malignant tissues and those obtained post-PDT treatment groups at 2 and 7 d a y s post A L A injection. The peaks and valleys of a line profile represent increases and decreases of the light intensity along the line selected in the image. Their width and magnitude are proportional to the size and intensity of their related regions. Figure 3 (A) shows how a bright fluorescence with uniform intensity appears in the profile as RGB peaks, red peaks are the main component of the profile. The images showed the higher the photosensitizer uptake increasing the contrast between tumour tissue and its surrounding tissues the steeper the intensity of the peaks. Noisy pixels, on the other hand, produce a series of narrow peaks figure 3 (B, C) , the concentration of inactivated photosensitizer, showed homogeneous intensity distribution shifted to the right figure 3 (D) . Normal tissue layers provided fluorescence spectra exhibiting a broad-continuum emission between 300 and 700 nm with peak fluorescence of equal intensity, the dominant peaks is for green colour pixels figure 4 (A) . This figure showed some green bright fluorescence as photosensitizer eliminated quickly from healthy cells. This profile characterized by a low noisy peaks, that disappeared rather than present any significant peak, which obviously shown in figures 4 (B & C). Figure (D) reflects a homogeneous small intensity peak conform the low sensitizer concentration uptake. Regarding activated photosensitizers' profile it showed two different sequences of RGB intensities characterization the first was just after applying PDT to activate the drug (photosensitizer), it was noticed that RGB profile peak still showed high peaks of the red colour, blue and green peaks, figure 5 (B, C), the intensity peak also showed high concentration due to that photosensitizer uptake and accumulation inside tumour tissues, the peak showed homogeneous high peak shifted to the right figure 5 (D). This pattern completely differed one week later as photosensitizer started its effect on tissue led to tissue damage and generation of singlet oxygen and free radical. The damaged tissues still gave rise to RGB profile closed to that obtained from normal tissue, the dominant peak is for green but the red and blue peaks still presented but with low peak than showed in malignant and treated tissues just after applying PDT figure 6 (A, B and C), the intensity peak showed remarks for what obtained from normal intensity but with high peak shifted to the right figure 6 (D). 
VI. Discussion:
One of the challenges imposed upon in vivo fluorescence imaging is tissue turbidity, or the influence of absorption and scattering on the fluorescence signal. The present work tried to use the PDT effect to study the uptake of photosensitizer as spatial fluorescence signals, in accordance of this approach Weber JR, et al., 2011 proved that using spatial tissue imaging technique could be useful to study the characterizing spatially and spectrally varying tissue optical properties [14] . Also Sheng C, et al., 2004 demonstrated that the fluorescence probe tool they were studied for quantifying PS levels and tissue damage are necessary for the understanding of PDT effect and therapeutic ratio in experimental in vivo tumor research [15] . Thomas J. Farrell, et al., in 1998 mentioned that there was a relationship between the decreasing fluorescence signal and the increasing depth of tissue photodynamic damage during treatment and by analyzing spatially resolved fluorescence measured at the tissue surface in terms of an equivalent virtual point or planar source of fluorescence within the tissue [16] . The uptake and retention of i.v. administered photosensitizer by tumor tissue is one of several fundamental determinants of the clinical effectiveness of PDT as mentioned by Weersink, R. A., et al., 1997, Chen, Q., et  al., 1996, Love, W. G., et al., 1996 and Windahl, T., et al., 1993 which comply with our obtained results that study of PS tissue uptake reflects many aspects that facilitate the understanding and how we can optimally benefit from this useful treatment modality [17] [18] [19] [20] . Using Matlab to study and analyze tissue auto fluorescence was applied by Kamath SD and Mahato KK 2007 the demonstrated that Matlab is a good tool for the spectral analysis and classification for discrimination of autofluorescence spectra of pathologically certified normal, premalignant, and malignant oral tissues [21] . Korbelik, M. 1993, stated that the most sensitive means of monitoring photosensitizer photodegradation is fluorescence detection and it is therefore important as far as possible to study photodegradation of photosensitizer in tumour tissues under treatment with PDT compared to normal tissues so that a cleaner correlation between photodegradation (fluorescence decreasing) and photodamage may be made [22] . In addition Ochsner, M. 1997 mentioned that the understanding of the pattern of the photosensitizer fluorescence -photobleaching -is important for the development of monitoring photodynamic therapy efficacy [23] . Pogue, B.W. and Burke, G. 1998 proved that the spatial fluorescence measurements can provide information about PS concentration in different tumors and in different areas within a tumor [24] . In agreement with our present study Jain RK. 2001 observed that the variation of PS concentration at different areas of tumor can be explained by the variations in these PS transport processes, e.g., different vasculature architecture, capillary permeability, and tumor interstitial diffusivity [25] . Consistent with the present thesis obtained results and the imaging system used to follow up methylene blue tumour tissues uptake and photodegradation with fluorescence imaging, SEYED MOHAMED ALI and MALINI OLIVO 2002, studied the biodistribution and subcellular localization of hypercin by using spectrofluorimetry and confocal laser scanning microscopy and determined cellular uptake and localizing of hypercin HY [26] . Agreed with what concluded of David I et al., 1999 that they study the effect of interstitial photodynamic therapy (PDT) in normal lung parenchyma to assess its potential for treating localized, peripheral lung tumors on Wistar rats using the photosensitizer [27] . Drug distribution was measured by fluorescence microscopy on tissue sections. Fluorescence was detected in the range 630 to 680 nm using a combination of bandpass and longpass filters. The charge-coupled device (CCD) sensor was used for imaging.Their results showed that the drug was initially distributed throughout the lung, but was later predominantly in the vasculature, bronchi, and macrophages and its fluorescent decreased by the uptake of the photosensitizer [27] . Peng Q, et al., 1995 reported that using meso-tetrahydroxyphenyl chlorine in PDT for in normal and tumor tissues of mice bearing mammary carcinoma. The concentration of mTHPC in lung 1 day after injection being five times greater than after 3 days, the size of PDT lesions made at these two times using the same light doses was virtually the same [28] . STEFANAKI et al., 2003 concluded that in their study of treating Condyloma with PDT using ALA as photosensitizer to detect the uptake and distribution of ALA which were varied from 6 to 11 hr to detect the maximum accumulation and starting the PDT application [29] . In the present study tissue content of MB and its distribution could be used to determine the optimum concentration of MB and the optimum time to activate MB. Xiaoyuan Chen, et al., 2004 in their study for Near-Infrared Fluorescence Imaging of Integrin αvβ3 in Brain tumor Xenografts conform that Direct image of dissected tissues and organs revealed very good tumor-to-nontumor tissue ratios. They used a very sensitive, cryogenically cooled CCD camera allows for acquiring a fluorescence image which showed the contrast of fluorescence intensities of the tumor (T) to those of normal tissue (N). This conform what obtained from the present study [30] .
VII.
Conclusion:
Tissue ALA uptake monitoring considered an important factor that could influence the efficacy of PDT, which could be identified using i mage pro cessing and analysis fo r ALA phpotosensitizer tissue fluorescence images b y MAT LAB.
